Fas and FasL expression in leukocytes from Chronic Granulomatous Disease patients;Expresión de Fas y FasL en leucocitos de pacientes con Enfermedad Granulomatosa Crónica

Investigacion Clinica (Venezuela)

Volumn 53, Issue 2, 2012, Pages 157-167

  Montes Berrueta, Daniela ^a   Ramírez, Lorena ^a   Salmen, Siham ^a   Berrueta, Lisbeth ^a  

^a UNIVERSIDAD DE LOS ANDES   (Venezuela)

Author keywords

CGD; Fas FasL; Neutrophils; T lymphocytes

Indexed keywords

FAS ANTIGEN; FAS LIGAND; PROTEIN P47; PROTEIN P67; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ADULT; ARTICLE; CELL DEATH; CELL STIMULATION; CHRONIC GRANULOMATOUS DISEASE; CLINICAL ARTICLE; DNA SEQUENCE; ENZYME SYNTHESIS; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; NEUTROPHIL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; UPREGULATION;

ADOLESCENT; ADULT; ANTIGENS, CD95; FAS LIGAND PROTEIN; FEMALE; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; LEUKOCYTES; MALE; YOUNG ADULT;

EID: 84865316313     PISSN: 05355133     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Segal BH, Veys P, Malech H, Cowan MJ. Chronic granulomatous disease: lessons from a rare disorder. Biol Blood Marrow Transplant 2012; 17:S123-131.
2. Roos D, de Boer M, Kuribayashi F, Meischl C, Weening RS, Segal AW, Åhlin A, Nemet K, Hossle JP, Bernatowska-Matuszkiewicz E, Middleton-Price H. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 1996; 87:1663-1681.
3. Hampton MB, Vissers MC, Keenan JI, Winterbourn CC. Oxidant-mediated phosphatidylserine exposure and macrophage uptake of activated neutrophils: possible impairment in chronic granulomatous disease. J Leukoc Biol 2002; 71:775-781.
4. Yamamoto A, Taniuchi S, Tsuji S, Hasui M, Kobayashi Y. Role of reactive oxygen species in neutrophil apoptosis following ingestion of heat-killed Staphylococcus aureus. Clin Exp Immunol 2002; 129:479-484.
5. Fernandez-Boyanapalli RF, Frasch SC, McPhillips K, Vandivier RW, Harry BL, Riches DW, Henson PM, Bratton DL. Impaired apoptotic cell clearance in CGD due to altered macrophage programming is reversed by phosphatidylserine-dependent production of IL-4. Blood 2009; 113: 2047-2055.
6. Fadeel B, Ahlin A, Henter JI, Orrenius S, Hampton MB. Involvement of caspases in neutrophil apoptosis: regulation by reactive oxygen species. Blood 1998; 92:4808-4818.
7. Kasahara Y, Iwai K, Yachie A, Ohta K, Konno A, Seki H, Miyawaki T, Taniguchi N. Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/APO-1)-mediated apoptosis of neutrophils. Blood 1997; 89:1748-1753.
8. Kobayashi SD, Voyich JM, Braughton KR, Whitney AR, Nauseef WM, Malech HL, DeLeo FR. Gene expression profiling provides insight into the pathophysiology of chronic granulomatous disease. J Immunol 2004 172:636-643.
9. Rieber N, Hector A, Kuijpers T, Roos D, Hartl D. Current concepts of hyperinflammation in chronic granulomatous disease. Clin Dev Immunol 2012; 2012:252460. Epub 2011 Jul 25.
10. Henson PM, Hume DA. Apoptotic cell removal in development and tissue homeostasis. Trends Immunol 2006; 27:244-450.
11. Sanmun D, Witasp E, Jitkaew S, Tyurina YY, Kagan VE, Ahlin A, Palmblad J, Fadeel B. Involvement of a functional NADPH oxidase in neutrophils and macrophages during programmed cell clearance: implications for chronic granulomatous disease. Am J Physiol Cell Physiol 2009; 297:C621-631.
12. Sanford AN, Suriano AR, Herche D, Dietzmann K, Sullivan KE. Abnormal apoptosis in chronic granulomatous disease and autoantibody production characteristic of lupus. Rheumatology (Oxford) 2006; 45:178-181.
13. Abrams SI. Positive and negative consequences of Fas/Fas ligand interactions in the antitumor response. Front Biosci 2005; 10:809-821.
14. Nagata S, Golstein P. The Fas death factor. Science 1995; 267:1449-1456.
15. Salmen S, Teran G, Borges L, Goncalves L, Albarran B, Urdaneta H, Montes H, Berrueta L. Increased Fas-mediated apoptosis in polymorphonuclear cells from HIV-infected patients. Clin Exp Immunol 2004; 137:166-172.
16. Luo J, Sun Y, Lin H, Qian Y, Li Z, Leonard SS, Huang C, Shi X. Activation of JNK by vanadate induces a Fas-associated death domain (FADD)-dependent death of cerebellar granule progenitors in vitro. J Biol Chem 2003; 278:4542-4551.
17. Salmen S, Corte D, Goncalves L, Barboza L, Montes H, Calderon A, Berrueta L. CD40/CD40L expression in leukocytes from chronic granulomatous disease patients. APMIS 2007; 115:939-947.
18. Jahanmehr SA, Hyde K, Geary CG, Cinkotai KI, Maciver JE. Simple technique for fluorescence staining of blood cells with acridine orange. J Clin Pathol 1987; 40:926-929.
19. Woodman RC, Newburger PE, Anklesaria P, Erickson RW, Rae J, Cohen MS, Curnutte JT. A new X-linked variant of chronic granulomatous disease characterized by the existence of a normal clone of respiratory burst-competent phagocytic cells. Blood 1995; 85:231-241.
20. Noack D, Rae J, Cross AR, Munoz J, Salmen S, Mendoza JA, Rossi N, Curnutte JT, Heyworth PG. Autosomal recessive chronic granulomatous disease caused by novel mutations in NCF-2, the gene encoding the p67-phox component of phagocyte NADPH oxidase. Hum Genet 1999; 105:460-467.
21. Salmen S, Berrueta L, Heyworth P, Borges L, Hernandez M, Munoz J. The NADPH-oxidase complex in chronic granulomatous disease: preliminary description of a cluster in Merida-Venezuela. Invest Clin 1999; 40:277-300.
22. Fernandez-Boyanapalli R, McPhillips KA, Frasch SC, Janssen WJ, Dinauer MC, Riches DW, Henson PM, Byrne A, Bratton DL. Impaired phagocytosis of apoptotic cells by macrophages in chronic granulomatous disease is reversed by IFN-gamma in a nitric oxide-dependent manner. J Immunol 2010; 185:4030-4041.
23. Schappi MG, Jaquet V, Belli DC, Krause KH. Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase. Semin Immunopathol 2008; 30:255-271.
24. Sauer H, Wartenberg M, Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem 2001; 11:173-186.
25. Jackson SH, Devadas S, Kwon J, Pinto LA, Williams MS. T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Immunol 2004; 5:818-827.
26. Kraaij MD, Savage ND, van der Kooij SW, Koekkoek K, Wang J, van den Berg JM, Ottenhoff TH, Kuijpers TW, Holmdahl R, van Kooten C, Gelderman KA. Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species. Proc Natl Acad Sci U S A 2010; 107:17686-17691.
27. Brown JR, Goldblatt D, Buddle J, Morton L, Thrasher AJ. Diminished production of anti-inflammatory mediators during neutrophil apoptosis and macrophage phagocytosis in chronic granulomatous disease (CGD). J Leukoc Biol 2003; 73:591-599.
28. Romani L, Fallarino F, De Luca A, Montagnoli C, D'Angelo C, Zelante T, Vacca C, Bistoni F, Fioretti MC, Grohmann U, Segal BH, Puccetti P. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 2008; 451:211-215.
29. Jackson SH, Gallin JI, Holland SM. The p47phox mouse knock-out model of chronic granulomatous disease. J Exp Med 1995; 182:751-758.
30. Opferman JT. Apoptosis in the development of the immune system. Cell Death Differ 2008; 15:234-242.
31. Opferman JT, Korsmeyer SJ. Apoptosis in the development and maintenance of the immune system. Nat Immunol 2003; 4:410-415.
32. Feig C, Peter ME. How apoptosis got the immune system in shape. Eur J Immunol 2007; 37 Suppl 1:S61-70.
33. Kaufmann T, Strasser A, Jost PJ. Fas death receptor signalling: roles of Bid and XIAP. Cell Death Differ 2012; 19:42-50.
34. Alcouffe J, Therville N, Segui B, Nazzal D, Blaes N, Salvayre R, Thomsen M, Benoist H. Expression of membrane-bound and soluble FasL in Fas-and FADD-dependent T lymphocyte apoptosis induced by mildly oxidized LDL. FASEB J 2004; 18:122-124.
35. Devadas S, Zaritskaya L, Rhee SG, Oberley L, Williams MS. Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and fas ligand expression. J Exp Med 2002; 195:59-70.
36. Zhang J, Gao JX, Salojin K, Shao Q, Grattan M, Meagher C, Laird DW, Delovitch TL. Regulation of fas ligand expression during activation-induced cell death in T cells by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase. J Exp Med 2000; 191:1017-1030.
37. Bernuth H, Kulka C, Roesler J, Gahr M, Rosen-Wolff A. NADPH oxidase is not required for spontaneous and Staphylococcus aureus-induced apoptosis of monocytes. Ann Hematol 2004; 83:206-211.
38. Krammer PH. CD95's deadly mission in the immune system. Nature 2000; 407:789-795.
39. Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W, Debatin KM, Krammer PH. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989; 245:301-305.
40. Lavrik IN, Krammer PH. Regulation of CD95/Fas signaling at the DISC. Cell Death Differ 2012; 19:36-41.
41. Bauer MK, Vogt M, Los M, Siegel J, Wesselborg S, Schulze-Osthoff K. Role of reactive oxygen intermediates in activation-induced CD95 (APO-1/Fas) ligand expression. J Biol Chem 1998; 273:8048-8055.
42. Baran J, Weglarczyk K, Mysiak M, Guzik K, Ernst M, Flad HD, Pryjma J. Fas (CD95)-Fas ligand interactions are responsible for monocyte apoptosis occurring as a result of phagocytosis and killing of Staphylococcus aureus. Infect Immun 2001; 69:1287-1297.